51 results
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
29 Mar 24
TherapeuticsMD Announces Full Year 2023 Financial Results
4:29pm
totaled $4.3 million.
About TherapeuticsMD
TherapeuticsMD was previously a women’s healthcare company with a mission of creating and commercializing
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
is appropriate or necessary.
About TherapeuticsMD
TherapeuticsMD was previously a women’s healthcare company with a mission of creating
8-K
EX-99.1
yyz53l 746ogwc
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
8-K
EX-99.1
5ldkg4g2jwj
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
2nsjze5ka
15 Aug 22
TherapeuticsMD Announces Second Quarter 2022 Financial Results
7:15am
SC 14D9
rjn0r7p
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
qefp ewy5
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-C
EX-99.1
121dlzgxvgt
31 May 22
Information about tender offer
10:02am
SC14D9C
EX-99.1
8cnld625
31 May 22
Written communication relating to third party tender offer
7:55am
8-K
EX-99.1
15yrnk4vzsudrosnou
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-99.1
15xep9wyfbjm heiwsw
14 Apr 22
TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million
4:25pm
POS AM
s3e6k87
23 Mar 22
Prospectus update (post-effective amendment)
6:06pm